Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
A series of seven cases are presented in which intravenous vitamin C has been used as antineoplastic agent in the treatment of different types of cancers. The cancers cases reviewed are the following: Renal cell carcinoma (2), Colorectal cancer (1), Pancreatic cancer (1), Non-Hodgkin's lymphoma (2) and breast cancer (1). Toxic reactions were not observed at these high doses of intravenous Vitamin C. All patients were prescreened for Glucose 6--phosphate dehydrogenase deficiency before administering intravenous Vitamin C in order to prevent hemolysis.
Riordan
Hugh D
HD
Center for the Improvement of Human Functioning, RENAC Project, Wichita, KS, USA.
Riordan
Neil H
NH
Jackson
James A
JA
Casciari
Joseph J
JJ
Hunninghake
Ron
R
González
Michael J
MJ
Mora
Edna M
EM
Miranda-Massari
Jorge R
JR
Rosario
Norberto
N
Rivera
Alfredo
A
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000975:Antioxidants / Q000008:administration & dosage* / Q000009:adverse effects; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D000975:Antioxidants; D001205:Ascorbic Acid